NCT05112861: An ongoing trial by Outlook Therapeutics, Inc.
This trial is ongoing. It must report results 3 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05112861 |
|---|---|
| Title | A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus PFS in Subjects With Visual Impairment Due to Retinal Disorders, NORSE SEVEN |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 15, 2021 |
| Completion date | March 31, 2025 |
| Required reporting date | March 31, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |